News Formal

Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales

  • 📰 NBCLA
  • ⏱ Reading Time:
  • 38 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 59%

Nederland Nieuws Nieuws

Nederland Laatste Nieuws,Nederland Headlines

The first-quarter results come as Merck shows substantial progress in preparing for Keytruda’s patent expiration in 2028.

Merck reported first-quarter revenue and adjusted earnings that topped expectations as it posted strong sales of its blockbuster cancer drug Keytruda and vaccine products.

The company expects full-year adjusted earnings of $8.53 to $8.65 per share, up from its prior forecast of $8.44 to $8.59 per share.of Harpoon Therapeutics in January. The company develops immune-based cancer drugs. The guidance also includes a negative impact of 30 cents per share from foreign exchange changes.

Excluding acquisition and restructuring costs, Merck earned $2.07 per share for the first quarter. Both adjusted and non-adjusted profit for the period include the charge related to the Harpoon deal.patent expiration Merck is also cutting costs under a new restructuring program it announced in February. Those efforts aim to improve the manufacturing network of both its pharmaceutical division and animal health business.

Wij hebben dit nieuws samengevat zodat u het snel kunt lezen. Bent u geïnteresseerd in het nieuws, dan kunt u hier de volledige tekst lezen. Lees verder:

 /  🏆 319. in NL
 

Bedankt voor uw reactie. Uw reactie wordt na beoordeling gepubliceerd.

Nederland Laatste Nieuws, Nederland Headlines

Similar News:Je kunt ook nieuwsberichten lezen die vergelijkbaar zijn met deze die we uit andere nieuwsbronnen hebben verzameld.

Stocks making the biggest moves premarket: Robinhood, GameStop, Merck and moreThese are the stocks posting the largest moves in premarket trading.
Bron: CNBC - 🏆 12. / 72 Lees verder »

Stocks making the biggest moves midday: GameStop, Merck, Carnival, Cintas and moreThese are the stocks posting the largest moves in midday trading.
Bron: CNBC - 🏆 12. / 72 Lees verder »

Cramer's week ahead: Earnings from Tesla, Merck and Big TechCNBC’s Jim Cramer said next week’s PCE index report will be the real gauge of inflation.
Bron: NBCLA - 🏆 319. / 59 Lees verder »

Cramer’s week ahead: Earnings from Tesla, Merck and Big TechCNBC's Jim Cramer said next week's PCE index report will be the real gauge of inflation.
Bron: CNBC - 🏆 12. / 72 Lees verder »